Update in Cystic Fibrosis 2014

Am J Respir Crit Care Med. 2015 Sep 15;192(6):669-75. doi: 10.1164/rccm.201504-0656UP.

Authors

Thida Ong^{1

2}, Bonnie W Ramsey^{1

3}

Affiliations

¹ 1 Department of Pediatrics, University of Washington, Seattle, Washington.
² 2 Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, Seattle, Washington; and.
³ 3 Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington.

PMID: 26371812
DOI: 10.1164/rccm.201504-0656UP

No abstract available

Publication types

Review

MeSH terms

Aminophenols / therapeutic use
Aminopyridines / therapeutic use
Benzodioxoles / therapeutic use
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Cystic Fibrosis* / drug therapy
Cystic Fibrosis* / genetics
Cystic Fibrosis* / microbiology
Cystic Fibrosis* / physiopathology
Genetic Markers
Humans
Mucociliary Clearance / physiology
Quinolones / therapeutic use
Treatment Outcome

Substances

Aminophenols
Aminopyridines
Benzodioxoles
Genetic Markers
Quinolones
Cystic Fibrosis Transmembrane Conductance Regulator
ivacaftor
lumacaftor